Skip to the card

Card 341 of 9832026-09-12 issue

Observed arrival · 2026-09-12

HeartMend’s five-gene second read for cardiac biopsies

heartmendtechnology.org Observed source
Editorial interest 78/100 Selection signal · not a rating of the site

A molecular diagnostic panel that scores acute cellular rejection risk from the same tissue collected for routine heart-transplant biopsy.

Landing page captured for the 2026-09-12 issue.

Field notes

The workflow uses a portion of the same endomyocardial biopsy collected for routine histology, measures five named genes, and applies an L2-regularized logistic regression model without refitting to new cohorts. The site reports testing on 25 external biopsies—12 rejection and 13 non-rejection—after training on 43 separate samples, with 2,000 permutation-test label shuffles. These are site-reported validation figures, not evidence here of regulatory clearance or routine clinical deployment.

Observed signals

Read the marks

Editorial observations of this landing page, not a rating.

○OpenPublic substance visible
✦PrettyNotable craft visible
●ProPolished or operationally mature
◎NicheUnusually specific use
◉HumanPersonal, local, civic, or handmade

One card from the complete issue

Radio Range Becomes Geography

352,465 arrived 1,000 judged 983 catalogued Enter the complete issue
heartmendtechnology.org

Landing page observed 2026-09-12. The live site may have changed.